Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
Stanford Medicine's Kevin Schulman says digitally enabled care (DEC) would ease clinical workload and improve services for patients beyond virtual visits.
Some researchers and clinicians are questioning the value of the body mass index, which estimates a person’s body composition. But do better alternatives exist?
New Stanford Medicine podcast, Health Compass, focuses on the crucial research and important researchers moving health topics forward.
Stanford Medicine scientists are studying why even brief trips into space can weaken muscle and heart tissue, mimicking decades of aging on Earth.
‘We’re like inflammation detectives!’ says Stanford Medicine’s Jennifer Frankovich. Parsing out pain and inflammation is just part of discovering why kids face debilitating psychiatric effects of a distressing disease.
The so-called ‘forever chemicals’ can stick around in the environment — and in our bodies. Scientists agree there is cause for concern. So what should we be doing to mitigate our health risks?
Many women experience extreme mood fluctuations as they approach menopause. Stanford Medicine’s Karen Adams says knowledge and access are key to aiding this normal condition.
Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.
By further segmenting study results, Stanford Medicine’s Irogue Igbinosa and collaborators have begun to tease out important health differences between different subsets of the population.
An Ask Me Anything Q&A with Stanford Medicine's Sharon Chinthrahjah, and expert on all things allergy-related.
A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.
A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.
In his grief over losing his wife, Amir Bahmani realized how much data science could impact medicine and potentially save lives.
Many social determinants of health can influence a patient’s risk, but Palaniappan and fellow researchers have noticed, from working with data from patients around the nation, that race is not among the most accurate or equitable.
Quenton Rashawn Bubb continues to value the complex, complementary nature of work on parallel paths -- not just as a musician/academic, but now on the path to his career.
